This inventor holds 1 USPTO granted patent. Top assignee: Korea University Research and Business Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kijeong Lee: Innovator in Pharmaceutical Composition
Introduction
Kijeong Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of allergic diseases. His innovative work has led to the development of a unique pharmaceutical composition that holds promise for treating various allergic conditions.
Latest Patents
Kijeong Lee holds a patent for a "Pharmaceutical Composition Containing SIRT7 Inhibitor for Preventing or Treating Allergic Diseases." This patent represents a significant advancement in the treatment of allergies, showcasing his expertise and dedication to improving healthcare outcomes.
Career Highlights
Kijeong Lee is affiliated with the Korea University Research and Business Foundation, where he continues to engage in groundbreaking research. His work not only highlights his innovative spirit but also reflects his commitment to advancing medical science.
Collaborations
Kijeong has collaborated with notable colleagues, including Tae-Hoon Kim and Junhyoung Byun. These partnerships have further enriched his research endeavors and contributed to the success of his projects.
Conclusion
Kijeong Lee's contributions to the field of pharmaceuticals, particularly through his patent on SIRT7 inhibitors, underscore his role as a leading inventor in the industry. His work continues to pave the way for new treatments for allergic diseases, demonstrating the impact of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile